CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

基因编辑技术作为基因工程、代谢工程、医学研究等领域的重要技术，一直以来都是研究热点。通过精确修改生物体的基因组序列，基因编辑技术可以对生物遗传信息进行精准操控，为探索生命奥秘、治疗遗传疾病、改善农业生产及推动生物产业发展提供了无限可能。

基因编辑技术近年来迅速发展，尤其是著名的CRISPR/Cas9工具，使我们在医学与农业等领域的应用前景广阔。CRISPR，源自细菌，为抵御病毒而演化出的防御机制，现被应用于精确修改DNA，宛如科学界的"基因魔剪"。

Both Cas9 and Cas12a cleave DNA, but they differ in how they cut the molecule.

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

2024年，生物医药行业不乏突破。CRISPR/Cas9基因编辑技术走向商业化；GLP-1减肥药国内上市，将公众的目光前所未有地吸引到减 ...

It's clear though that these companies need time. Even with the only approved CAS9 based treatment out there, CRISPR is still years away from achieving its potential. In a recent update to ...

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), ...